Chinese COVID-19 vaccine appears safe in early human trial - Tv9
Sun, May 24, 2020, 03:51 PM
Amid the coronavirus threat all across the World, the medical research teams of many countries have been advancing towards developing a vaccine meant for the deadly COVID-19 virus. Reports suggest that the coronavirus vaccine developed by China's CanSino Biologics has appeared safe in early human trials. The vaccine is named as Ad5-nCoV. In the first trial, the vaccine is tried on 108, and after 28 days, the results are seen promising.
On the other hand, the vaccine developed by Oxford University has successfully entered into the second phase after completing the first trial.
Watch the video for more insight.